Locations:

Cancer

November 2, 2023/Cancer/Radiation Oncology

Studying Ultra-Hypofractionated Radiotherapy for Soft Tissue Sarcoma

Meta-analysis suggests efficacy and safety

23-CNR-4274323-CQD-pagets disease of the breast

October 30, 2023/Cancer/Surgical Oncology

Paget’s Disease of the Breast a Little Understood Form of DCIS

Rare cancer presents as unresolved changes of the nipple

23-CNR-4270908-CQD-Hero-Dr Mukherjee rare cancers 650×450

October 26, 2023/Cancer/News & Insight

Cleveland Clinic Cancer Center and National Organization for Rare Disorders Partner to Accelerate Diagnosis and Treatment of Rare Cancers

Dedicated multidisciplinary teams support 84 ultra-rare cancers

October 23, 2023/Cancer/Research

p53-Independent Non-Cytotoxic Therapy May be a Viable Option for Chemotherapy-Resistant Small Cell Lung Cancer

Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-CNR-4044609-CQD-Hero-650×450 AML study

October 20, 2023/Cancer/Research

The Role of Immune Escape in Post-Transplant Leukemia Relapse

Immunological pressure driving genetic mutations

23-CNR-4044611-CQD-Hero-650×450. Dr Chaojpg

October 16, 2023/Cancer/Research

Adding EGFR-Directed Systemic Treatment of Stereotactic Radiosurgery May Improve Control of Brain Metastases in Non-Small Cell Lung Cancer

New review published in Cancers suggests a synergistic benefit

23-CNR-4162210-CQD-Hero-650×450 Dr Khorana

October 12, 2023/Cancer/Research

Study Delves into the Mechanisms Causing Venous Thromboembolism in Patients Receiving Immunotherapies

Clinicians highlight the need to educate patients about warning signs

October 9, 2023/Cancer/News & Insight

Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

October 6, 2023/Cancer/Surgical Oncology

Surgical De-Escalation for Benign High-Risk Breast Lesions

Are we ready for ‘observation’ of lesions found on core needle biopsy?

23-CNR-4210969-CQD-Hero1-650×450 Dr Amarnath

October 6, 2023/Cancer/Research

Quality Metrics and Quality Improvement Program Can Improve Cervical Cancer Care

A new analysis emphasizes the value of a multi-disciplinary approach.

BackPage 10 of 137Next